Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review

BACKGROUND: Selective estrogen receptor modulators, such as tamoxifen, reduce breast cancer risk by up to 50% in women at increased risk for breast cancer. Despite tamoxifen’s well-established efficacy, many studies show that most women are not taking up tamoxifen. This systematic literature review...

Descripción completa

Detalles Bibliográficos
Autores principales: Meiser, B., Wong, W. K. T., Peate, M., Julian-Reynier, C., Kirk, J., Mitchell, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607482/
https://www.ncbi.nlm.nih.gov/pubmed/28943990
http://dx.doi.org/10.1186/s13053-017-0075-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607482/
https://www.ncbi.nlm.nih.gov/pubmed/28943990
http://dx.doi.org/10.1186/s13053-017-0075-8

Ejemplares similares